SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (499)4/16/1998 1:47:00 PM
From: Jim Mac  Read Replies (2) of 1754
 
There's a lot of confusion concerning exactly what FTC is trying to do. Here's the deal:

Visx and Summit contributed all their respective patents to PPP, which then licenses all these patents back to Visx and Summit, which in turn sublicense the PPP patents to their users.

FTC is seeking to stop this SUBLICENSING OF PPP PATENTS, because PPP is a patent pooling thing which FTC thinks is a monopolistic practice.

FTC is NOT seeking to stop Visx and Summit from separately licensing their respective patents to respective users.

FTC only want to stop the PPP pooling deal. FTC wants Visx and Summit to license users SEPARATELY, and collect fees on respective lasers without subsequently putting money into the PPP pot for later splitting.

Is that clear, everyone?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext